Proper Wnt signaling is critical to regulate numerous processes including cellular polarity, multiplication of cells, and cellular differentiation.[@i1552-5783-60-1-107-b01]--[@i1552-5783-60-1-107-b03] These processes are initiated by one of three major signaling cascades that are activated once secreted Wnt ligands bind their Frizzled (FZD) transmembrane receptors.[@i1552-5783-60-1-107-b04],[@i1552-5783-60-1-107-b05] The most well-studied pathway in Wnt signaling is the canonical Wnt/β-catenin pathway. Canonical signaling prevents the degradation of β-catenin when Wnt binds to FZD and its coreceptor LRP5/6. This allows β-catenin to translocate into the nucleus to transcriptionally activate genes.[@i1552-5783-60-1-107-b01],[@i1552-5783-60-1-107-b06],[@i1552-5783-60-1-107-b07] Other signals mediated by Wnt-FZD binding are the noncanonical pathways, including the Wnt/c-Jun N-terminal Kinase (JNK) pathway, and the Wnt/Ca^2+^ pathway, which are both β-catenin independent and are involved in regulating cellular polarity and migration.[@i1552-5783-60-1-107-b04],[@i1552-5783-60-1-107-b08]

Because many cellular processes are controlled through Wnt activation, it is not surprising that Wnts are involved in modulating stem cells that go through periods of quiescence, proliferation, and differentiation. The expression of Wnt has been found in a variety of cell types including embryonic,[@i1552-5783-60-1-107-b09][@i1552-5783-60-1-107-b10]--[@i1552-5783-60-1-107-b11] hair follicle,[@i1552-5783-60-1-107-b12],[@i1552-5783-60-1-107-b13] and intestinal stem cells.[@i1552-5783-60-1-107-b14],[@i1552-5783-60-1-107-b15] Furthermore, additional stem cell populations regulated by the Wnt pathway are continuously being discovered, especially in replenishing tissues, such as the cornea. The cornea is the very first structure that light encounters as it enters the eyes, and the epithelium is constantly regenerated.[@i1552-5783-60-1-107-b16][@i1552-5783-60-1-107-b17][@i1552-5783-60-1-107-b18]--[@i1552-5783-60-1-107-b19] The corneal epithelium must be regenerated because the epithelial cells are constantly shed as we blink and rub our eyes to maintain hydration and remove debris. The inability to replenish corneal epithelial cells results in the deterioration and/or loss of vision.[@i1552-5783-60-1-107-b20],[@i1552-5783-60-1-107-b21] Stem cells for the corneal epithelium have been found in the limbal epithelium and are thus identified as limbal stem/progenitor cells (LSCs).[@i1552-5783-60-1-107-b22][@i1552-5783-60-1-107-b23]--[@i1552-5783-60-1-107-b24] We have previously shown that Wnt signaling was present in the LSC niche, and specific Wnt molecules and inhibitors were differentially expressed between the limbus and cornea.[@i1552-5783-60-1-107-b25],[@i1552-5783-60-1-107-b26] Subsequently, studies have supported the importance of Wnt in the regulation of LSCs by demonstrating increased proliferation upon in vitro activation of Wnt.[@i1552-5783-60-1-107-b25][@i1552-5783-60-1-107-b26][@i1552-5783-60-1-107-b27]--[@i1552-5783-60-1-107-b28]

The canonical Wnt signaling cascade is initiated once Wnt establishes an interaction with the FZD and LRP5/6 coreceptors. This signaling is regulated by several Wnt inhibitors; one of those is Dickkopf (DKK),[@i1552-5783-60-1-107-b29] as it blocks Wnt signaling by binding to LRP5/6. Studies by Li et al.[@i1552-5783-60-1-107-b30] showed that DKK can be effectively inhibited by a small molecule, IIIC3 (Gallocyanine); thus IIIC3 activates Wnt signaling.[@i1552-5783-60-1-107-b29] On the other hand, another small molecule, IC15, binds to the Wnt binding site of LRP5/6 and inhibits Wnt signaling.[@i1552-5783-60-1-107-b29] Therefore, pairing IIIC3 and IC15 together makes a perfect tool to probe canonical Wnt signaling in biological systems.

Previously, studies have only targeted factors after Wnt receptor binding, and until now small-molecule studies on Wnt receptors have not been performed on limbal epithelial cells (LECs). Here, using the two small molecules, we demonstrate the effect of activating and prohibiting Wnt signaling on human primary LECs in vitro. By activating Wnt with IIIC3 or preventing Wnt activation by blocking Wnt-LRP5/6 interactions with IC15,[@i1552-5783-60-1-107-b30],[@i1552-5783-60-1-107-b31] the current study shows that Wnt is a key component in the preservation and proliferation of LSCs in culture.

Materials and Methods {#s2}
=====================

Human Corneoscleral Tissue {#s2a}
--------------------------

Human LSC cultures were derived from three sclerocorneal tissue donors (ages ≤ 75 years). All tissues were preserved in Optisol (Chiron Ophthalmics, Inc., Irvine, CA, USA) and obtained from CORE eye bank, Sightlife, and Lions eye bank. The death-to-preservation time in Optisol was less than 10 hours, and the time from death to experiment was 4 to 6 days. Experimental protocols were evaluated by the University of California, Los Angeles Institutional Review Boards and performed in accordance with the Declaration of Helsinki.

Isolation and Cultivation of Limbal Epithelial Cells {#s2b}
----------------------------------------------------

Isolation and cultivation of LSCs were performed as previously described.[@i1552-5783-60-1-107-b32] Briefly, LEC sheets were isolated from corneoscleral rims following incubation with 2.4 U/mL Dispase II (Roche, Indianapolis, IN, USA) in SHEM growth medium (DMEM/F12; Gibco, Carlsbad, CA, USA) supplemented with N-2 (Gibco), 2 ng/mL epidermal growth factor (EGF; Gibco), 8.4 ng/mL cholera toxin (Sigma-Aldrich Corp., St. Louis, MO, USA), 0.5 μg/mL hydrocortisone (Sigma-Aldrich Corp.), 0.5% dimethyl sulfoxide (DMSO; Sigma-Aldrich Corp.), and 5% fetal bovine serum (FBS; Invitrogen, Carlsbad, CA, USA) for 2 hours at 37°C. LEC sheets were gently lifted from the tissues and single cells were obtained by treatment with 0.25% trypsin-EDTA (Gibco) at 37°C for 5 minutes. The final concentration of DMSO was adjusted for all cultures to be 0.5% (vol/vol). The LEC single cells were seeded at 200 cells/cm^2^ on mitomycin-treated 3T3 cells (3 × 10^4^ 3T3 cells/cm^2^, from Howard Green, Harvard Medical School, Boston, MA, USA) in SHEM medium with the same final DMSO concentrations (0.5%). Each experiment used LSCs at passage 0.

To investigate the effect of the Wnt pathway on LSCs, IIIC3 (Sigma-Aldrich Corp.) or IC15 (Sigma-Aldrich Corp.) was added to the culture medium with final concentrations of 1, 5, 10, or 20 μM. Cultures without small molecules served as the control. Cell culture medium was routinely changed every 2 to 3 days containing the appropriate concentration of small molecules until collection between 12 to 14 days. The cultured LECs were then characterized.

Cell population doubling from all the conditions tested was calculated by using the formula Log~2~ (no. cells harvested/no. cells seeded).

The short-term effect of IIIC3 and IC15 treatment was also tested on freshly isolated LECs after 5-, 10- and 30-minute incubations with the most efficient (5 μM) and highest (20 μM) concentration of small molecules. After incubation, the cells were stained with trypan blue to determine cell viability.

Colony Forming Efficiency {#s2c}
-------------------------

Cells were fixed with 4% paraformaldehyde (ThermoFisher Scientific, Carlsbad, CA, USA) and stained for 15 minutes with 0.5% rhodamine B (Sigma-Aldrich Corp.) at room temperature. The number of cells plated was then divided by the number of colonies formed to obtain the CFE.

Immunocytochemistry {#s2d}
-------------------

Colonies were harvested with dispase (2.5 mg/mL; Roche) and treated with trypsin-EDTA (0.25%; Gibco) to isolate single cells. Single cells were counted using a hemocytometer and washed in SHEM growth medium before setting onto slides with a cytospin (Cytofuge; Fisher Scientific, Houston, TX, USA). Cells were fixed with 4% paraformaldehyde at 20°C for 10 minutes, washed with phosphate-buffered saline (PBS), incubated with 1% bovine serum albumin (BSA) and 0.5% Triton X-100 (Sigma-Aldrich Corp.) in PBS at 20°C for 30 minutes, and incubated with the following primary antibodies at 4°C overnight: K12 (Santa Cruz Biotechnology, Dallas, TX, USA; sc-25722, 1:100), K14 (Fisher Scientific; MS-115-R7, 1:50), p63α (Cell Signaling Technology, Danvers, MA, USA; 4892, 1:100), Ki67 (DAKO, Carpinteria, CA, USA; M7240, 1:100). Cells were washed with PBS, then incubated with the secondary antibodies goat anti-mouse IgG, Alexa Fluor 488 (ThermoFisher Scientific, A11029, 1:500), goat anti-rabbit IgG, Alexa Fluor 546 (ThermoFisher Scientific, A11035, 1:500) at 20°C for 1 hour. After washing with PBS, nuclei were labeled with Hoechst 33342 (4 μg/mL; Invitrogen) at 20°C for 15 minutes and mounted in Fluoromount medium (Sigma-Aldrich Corp.).

Images were taken with the digital inverted Keyence BZ-X710 fluorescence microscope (Osaka, Japan) and the image capture system BZ-X Viewer. Quantification of marker expression was performed by using the BZ-X analyzer software (version 1.3.0.3) and the hybrid cell count function. By specifying a mask area, the software extracts information on multiple parameters such as intensity of fluorescence signal in different channels, cell counts, and target area measurements. Cells expressing high levels of p63α (p63α^bright^ cells) were also quantified following this method as previously described.[@i1552-5783-60-1-107-b33]

Statistical Analysis {#s2e}
--------------------

Data obtained were analyzed using Student\'s *t*-test, and error bars represent calculations obtained from standard error of the mean (SEM). Significance was determined at *P* values ≤ 0.05.

Results {#s3}
=======

Morphology and Proliferation of LSCs Cultured With IIIC3 and IC15 Small Molecules {#s3a}
---------------------------------------------------------------------------------

The IIIC3 and IC15 small molecules were identified to bind YWTD repeat domains of LRP5/6, which included sites for DKK and Wnt binding.[@i1552-5783-60-1-107-b30] Studies have also shown IIIC3 to compete effectively against DKK at 5 μM, promoting Wnt activation. Alternatively, IC15 interfered with Wnt-LRP5/6 binding, and was found to inhibit Wnt signaling at concentrations above 1 μM.[@i1552-5783-60-1-107-b30] To investigate the effect of the Wnt pathway on LECs, single cells isolated from LEC sheets were cultured with varying concentrations (1, 5, 10, 20 μM) of IIIC3 and IC15.

Morphologic evaluation of LECs cultured with either small molecule showed similar cuboidal appearances to untreated control cells at all concentrations ([Fig. 1](#i1552-5783-60-1-107-f01){ref-type="fig"}A). Colony forming efficiency (CFE), an indicator of the amount of progenitor/stem cells, was also evaluated. The limbal epithelium is known to have a small population of stem/progenitor cells, typically less than 10%.[@i1552-5783-60-1-107-b34] Accordingly, untreated cells had an average CFE of 8.76%; however, treatment with the IC15 inhibitor resulted in significantly reduced CFE for all tested concentrations ([Figs. 1](#i1552-5783-60-1-107-f01){ref-type="fig"}B, [1](#i1552-5783-60-1-107-f01){ref-type="fig"}C). Inhibition of DKK with IIIC3 did not increase CFE compared to the control. CFE was significantly reduced upon exposure to the highest concentration of activator, 20 μM IIIC3. In parallel, cell population doubling displayed a similar pattern in which a decrease was detected with increasing concentrations of IC15 with significance at 10 and 20 μM, while population doubling was relatively similar at all concentrations apart from a significant decrease at 20 μM ([Fig. 1](#i1552-5783-60-1-107-f01){ref-type="fig"}D). As for the number of cells grown in culture, treatment with IC15 gradually reduced the number of cultivated LECs (16%--29%), while 5 μM IIIC3 increased cell number by 7.21% and 20 μM IIIC3 decreased it by 29.4% ([Fig. 1](#i1552-5783-60-1-107-f01){ref-type="fig"}E).

![Effect of IIIC3 and IC15 on limbal stem/progenitor cell (LSC) proliferation. (A) Treatment of LSCs with IIIC3 and IC15 did not change the cuboidal morphology. (B--E) Different concentrations of IIIC3 and IC15 affect colony forming efficiency (CFE) and cell proliferation of LSCs. IIIC3 treatment generated larger colonies while IC15 treatment generated colonies of smaller size (B). The CFEs obtained from IIIC3 treatment were similar to those for untreated controls except at the highest concentration of 20 μM. CFE was significantly reduced with all concentrations of IC15 (C). Cell population doubling calculated as Log~2~ (no. cells harvested/no. cells seeded) (D). Cell numbers were significantly increased with 5 μM IIIC3, but decreased in a dose-dependent manner for IC15 treatment, and 20 μM IIIC3 (E). \*P \< 0.05.](i1552-5783-60-1-107-f01){#i1552-5783-60-1-107-f01}

To determine if these differences were due to changes in the number of cells entering the cell cycle after small-molecule treatment, we assessed the cells for Ki67, which is highly expressed during the cell cycle but absent in quiescent cells.[@i1552-5783-60-1-107-b35] Calculations of Ki67^+^ percentages between cultures showed no significant differences between all tested concentrations of IIIC3 and IC15 treatment ([Fig. 2](#i1552-5783-60-1-107-f02){ref-type="fig"}B).

![LSCs continue to actively divide upon small-molecule treatment. (A) Immunostaining of Ki67 in LSCs treated with IIIC3 and IC15. (B) Ki67 expression is significantly increased in LSCs treated with 20 μM IIIC3. Percentage of Ki67^+^ cells showed no significant differences between all tested concentrations of IIIC3 and IC15. Scale bar: 20 μm. \*P \< 0.05.](i1552-5783-60-1-107-f02){#i1552-5783-60-1-107-f02}

To investigate whether the small molecules have direct cytotoxic effects on LECs, IIIC3 and IC15 were incubated with freshly isolated LECs for 5, 10, and 30 minutes. The cell viability was similar between control (92.2%--94%), IIIC3 (88.9%--98.1%), and IC15 (94.7%--96.1%) small-molecule groups at 5 μM (*P* \< 0.05), while at 20 μM, the percentage of trypan blue--stained cells increased for both IIIC3 (12.8%) and IC15 (7.6%) at 10 minutes but remained stable at 30 minutes compared to that of the control. This observation suggests that the effects at high concentrations were likely due to the inhibition of Wnt signaling alone.

Maintenance of LSC Phenotype After Small-Molecule Treatment {#s3b}
-----------------------------------------------------------

LSCs are distinguished from differentiated corneal cells through p63α expression.[@i1552-5783-60-1-107-b36],[@i1552-5783-60-1-107-b37] In order to confirm that the colonies contained specifically LSCs, the number of cells expressing high levels of p63α (p63α^bright^ cells) was quantified in the cultivated LEC population. The percentage of p63α^bright^ cells significantly increased by 4.71% with 5 μM IIIC3 activation (*P* = 0.04, [Figs. 3](#i1552-5783-60-1-107-f03){ref-type="fig"}A, [3](#i1552-5783-60-1-107-f03){ref-type="fig"}B), but inhibition of Wnt signaling with IC15 resulted in a significant loss of p63α^bright^ cells. Even with the lowest dose of 1 μM IC15 there was a decrease of 2.91% p63α^bright^ cells (*P* = 0.04), while at the highest concentration of 20 μM IC15 a 9.08% (*P* = 0.03) decrease was observed in addition to the significantly reduced total p63α^bright^ cell population (\>85,000 cells; *P* \< 0.05, [Fig. 3](#i1552-5783-60-1-107-f03){ref-type="fig"}C). Furthermore, cell size was evaluated as LSCs are typically quiescent with reduced cytoplasmic content, resulting in higher nuclear--cytoplasmic ratios and sizes smaller than 12 μm.[@i1552-5783-60-1-107-b38][@i1552-5783-60-1-107-b39]--[@i1552-5783-60-1-107-b40] Analyses revealed that the percentage of small cuboidal cells was significantly increased only with 5 μM of IIIC3 ([Fig. 3](#i1552-5783-60-1-107-f03){ref-type="fig"}D).

![Maintenance of limbal stem/progenitor cell (LSC) undifferentiated phenotype is IIIC3 concentration dependent. (A) Expression of p63α is retained in LSCs upon IIIC3 treatment but reduced with all tested concentrations of IC15. (B, C) Quantification of p63^bright^ cells showed a significant increase with 5 μM IIIC3. IC15 treatment reduced the percentage and the total number of p63^bright^ cells (D). The percentage of cells maintaining a cell size smaller than 12 μm was significantly increased with 5 μM IIIC3. There was a trend of decrease with IC15 treatment. \*P \< 0.05, \*\*P \< 0.001.](i1552-5783-60-1-107-f03){#i1552-5783-60-1-107-f03}

The LSCs are further characterized by the expression of the cytokeratin marker K14, while differentiation is marked by the expression of K12. Roughly 97% of LECs treated with either IIIC3 or IC15 retained the K14 marker, and the K12 differentiation marker was only significantly increased with 1 μM IIIC3, 1 μM IC15, and 5 μM IIIC3 ([Fig. 4](#i1552-5783-60-1-107-f04){ref-type="fig"}). As the differentiation was detected in only approximately 2% of cells, it appears that most LSCs remain in an undifferentiated state in culture.

![Expression of K14 is maintained by LSCs treated with IIIC3 or IC15. (A) Immunostaining of K14, the LSC marker, and K12, the differentiation marker. (B) Most cells retain K14 expression. (C) K12 is detected in a small population of LSCs, and is increased within a narrow range, 1 to 5 μM IIIC3 and 1 μM IC15. \*P \< 0.05.](i1552-5783-60-1-107-f04){#i1552-5783-60-1-107-f04}

Discussion {#s4}
==========

From the maintenance of stem/progenitor characteristics to promoting the multiplication of stem cells, many previous studies have examined the Wnt pathway to determine how cellular processes are regulated. Specifically, factors downstream of the Wnt--FZD interaction were targeted to either prevent or activate the transcription of genes. Recently, however, modifications to the primary components, such as the FZD and LRP5/6 receptors, or associated inhibitors, such as DKK, have also been demonstrated to have significant effects on cellular responses.[@i1552-5783-60-1-107-b30],[@i1552-5783-60-1-107-b41] As these previous studies demonstrated the potency of inhibitors and receptors on the Wnt pathway we decided to investigate how modulation of primary Wnt components using small molecules would affect LSCs in vitro. Our results show that inhibition of the Wnt inhibitor DKK using IIIC3 enhances the proliferation of LSCs in a dose-dependent manner, while inhibition of Wnt signaling using IC15 reduces the stem cell proliferation and quantity.

The concentration dependency that we have observed is most likely due to the binding locations of IIIC3. The extracellular domain of Wnt coreceptor LRP5/6 has four YWTD domains.[@i1552-5783-60-1-107-b30],[@i1552-5783-60-1-107-b41] Although IIIC3 preferably binds to the second YWTD repeat domain of LRP5/6 where DKK binds, the similarity among the four YWTD repeat domains of LRP5/6 may also result in IIIC3 binding to the third and fourth YWTD repeat domains of LRP5/6 at higher concentrations and block the Wnt binding sites.[@i1552-5783-60-1-107-b30],[@i1552-5783-60-1-107-b41] As a result IIIC3 may behave as an inhibitor at higher concentrations. Additionally, as previous studies have found 5 μM of IIIC3 to be the most effective concentration to activate canonical Wnt signaling,[@i1552-5783-60-1-107-b30] it appears that this concentration also efficiently improves proliferation of LSCs demonstrated by our 7.21% increase. However, 5 μM IIIC3 did not increase the CFE. This is not surprising as colony formation is limited by the number of LSCs seeded, which is only 10% of the limbus, at maximum. The CFE is further limited by the cell\'s potential to establish a colony, leave the quiescent stem state, and promote cellular division. These cells must also continue to maintain LSC characteristics during these proliferative states, such as small cell size and the expression of high levels of p63α. Both of these were significantly increased upon treatment with 5 μM IIIC3. Inhibition with IC15, however, significantly decreased the number of p63α^bright^ cells to a much larger extent as the total number of p63α^bright^ cells decreased by more than 85,000 cells with a small percentage being p63α^bright^ positive. At high IIIC3 concentrations, the LSC population did not increase, and appeared to have inhibitory effects as the number of cultured cells was reduced. This is expected because of the inhibitory binding sites of IIIC3 on LRP5/6 at high concentrations. As inhibition of Wnt signaling with IC15 significantly reduced cell proliferation and CFE, our results suggest that Wnt activity is present in the limbus and that it is required for LSC maintenance.

Short-term incubation of the LECs with 20 μM IIIC3 and IC15 showed a slight reduction in cell viability but remained stable after 10 minutes, whereas at 5 μM both small molecules did not show differences in cell viability compared to the control. If these small molecules did have direct cytotoxic effects, the viability would be expected to decrease in a linear fashion. The fact that the viability remained stable after 10 minutes suggests that the initial effect is likely due to inhibition of Wnt signaling at high concentrations (20 μM), and implies that Wnt signaling may be involved in LEC survival pathways, warranting further investigation.

We previously found that Wnt 2, 6, 11, and 16b were preferentially expressed in the limbus along with four Wnt inhibitors DKK1, Wnt inhibitory factor 1, FRZB, and secreted frizzled-related protein 5.[@i1552-5783-60-1-107-b26] We hypothesize that Wnt signaling is balanced by Wnt inhibitors during quiescent states, and these inhibitors must be modulated carefully to promote the proliferation and differentiation of LSCs. However, exactly how the Wnt pathway is regulated remains elusive due to the number and complexity of components and their roles in signaling.

In this study we conclude that the Wnt pathway is required in LSC proliferation and the maintenance of undifferentiated LSCs. Careful regulation of the Wnt pathway is critical as the levels can promote or decrease the efficiency of human LSC expansion. Further small-molecule studies on Wnt and their activities in LSC proliferation and differentiation are needed as they could have translational potential in maintaining a functional corneal epithelium, a major contributor to vision.
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